Abiopharma

Clinical trial NCT05974579 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-03-31 → 2026-03-31 3. enrollment: 12 → 8 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05369429 updates: 1. completion date: 2026-06-01 → 2028-07-05 2. primary completion date: 2026-06-01 → 2028-07-05

Clinical trial NCT07101081 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-23

Clinical trial NCT07069309 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-05 → 2026-05-01 3. primary completion date: 2026-05-05 → 2026-05-01 4. enrollment: 760 → 774 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03319901 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-04-30 → 2028-05-30 3. primary completion date: 2026-04-30 → 2025-11-25

Clinical trial NCT04750226 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-04-27 3. primary completion date: 2026-04-01 → 2026-04-27

Clinical trial NCT07279935 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-05-26

Clinical trial NCT03670368 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-05-31 → 2025-08-21 3. primary completion date: 2026-05-31 → 2025-08-21 4. enrollment: 500 → 416 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07394140 updates: 1. start date: 2026-02-01 → 2026-06-15 2. primary completion date: 2026-05-31 → 2026-10-31

Clinical trial NCT06360354 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2029-02-25 → 2026-11-30 3. primary completion date: 2027-02-26 → 2026-10-31 4. enrollment: 350 → 120 participants 5. enrollment type: ESTIMATED → ACTUAL